Trends and Dynamics of Respiratory Viruses in Hospitalized Children of Fuzhou: Insights Into the Impact of COVID-19 Pandemic Control Measures

被引:0
|
作者
Wu, Kunhai [1 ]
Huang, Huifang [2 ]
Chen, Lufei [1 ]
Wu, Yanan [3 ]
机构
[1] Fujian Med Univ, Fujian Matern & Child Hlth Hosp, Coll Clin Med Obstet & Gynecol & Pediat, Blood Transfus Dept, Fuzhou, Fujian, Peoples R China
[2] Fujian Med Univ, Fujian Matern & Child Hlth Hosp, Coll Clin Med Obstet & Gynecol & Pediat, Int Care Unit, Fuzhou, Fujian, Peoples R China
[3] Fujian Prov Hosp, Dept Clin Lab, Fuzhou, Fujian, Peoples R China
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2025年 / 18卷
关键词
children; coronavirus disease 2019; prevent and control measures; respiratory virus; INFECTION; HENAN;
D O I
10.2147/IJGM.S511995
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: This study aimed to investigate the prevalence of common respiratory viruses among children with acute respiratory infections in Fuzhou from 2017 to 2023, considering the varying Corona Virus Disease 2019 (COVID-19) epidemic control measures in place. Patients and Methods: This study retrospectively analyzed the detection of respiratory viruses in children diagnosed with acute respiratory infections at a tertiary hospital in Fuzhou during the study period. The analysis covers three distinct phases: Phase I (2017-2019), Phase II(2020-2022), and Phase III (2023). The subjects of this study included adenovirus (ADV), influenza A virus (Flu A), influenza B virus (Flu B), parainfluenza virus types 1, 2, and 3 (PIV-1, PIV-2, PIV-3), and respiratory syncytial virus (RSV). Results: A total of 24,838 throat swab samples were collected, resulting in an overall positive detection rate of 17.87% (4439/24,838). The positive detection rates of respiratory viruses among hospitalized children in Phases I, II, and III were 18.51%, 18.27%, and 15.90%, respectively, demonstrating a statistically significant decreasing trend over the years (P < 0.001). Among the detected viruses, RSV, PIV-3, and Flu A were the most prevalent. RSV infections was most common in children under six years of age. Seasonal trends for Flu A, PIV-3, and RSV varied throughout the outbreak; specifically, the detection rate of Flu A increased during March and April in 2023, while RSV detection rebounded sharply from April to June. The incidence of mixed respiratory virus infections was 0.40% (100/24,838), the most common being PIV-3 and RSV. Conclusion: Using COVID-19 safety rules has helped stop the spread of some viruses in kids. But these rules have not made much difference in how often RSV and PIV-3 viruses show up.
引用
收藏
页码:759 / 770
页数:12
相关论文
共 50 条
  • [21] Epidemiological Changes in Respiratory Viral Infections in Children: The Influence of the COVID-19 Pandemic
    Almeida, Teresa
    Guimaraes, Joao Tiago
    Rebelo, Sandra
    VIRUSES-BASEL, 2023, 15 (09):
  • [22] Circulating Trends of Influenza and Other Seasonal Respiratory Viruses among the US Department of Defense Personnel in the United States: Impact of the COVID-19 Pandemic
    Hu, Wenping
    Fries, Anthony C.
    DeMarcus, Laurie S.
    Thervil, Jeffery W.
    Kwaah, Bismark
    Brown, Kayla N.
    Sjoberg, Paul A.
    Robbins, Anthony S.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (10)
  • [23] Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemic
    Zhao, Chenkai
    Zhang, Tiantian
    Guo, Ling
    Sun, Shiqi
    Miao, Yumeng
    Yung, Chee Fu
    Tomlinson, Jane
    Stolyarov, Kirill
    Shchomak, Zakhar
    Poovorawan, Yong
    Nokes, David James
    Munoz-Almagro, Carmen
    Mandelboim, Michal
    Keck, James W.
    Langley, Joanne Marie
    Heikkinen, Terho
    Deng, Jikui
    Colson, Philippe
    Chakhunashvili, Giorgi
    Caballero, Mauricio T.
    Bont, Louis
    Feikin, Daniel R.
    Nair, Harish
    Wang, Xin
    Li, You
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [24] Impact of COVID-19 Pandemic in Children with CKD or Immunosuppression
    Mastrangelo, Antonio
    Morello, William
    Vidal, Enrico
    Guzzo, Isabella
    Annicchiarico Petruzzelli, Luigi
    Benetti, Elisa
    Materassi, Marco
    Giordano, Mario
    Pasini, Andrea
    Corrado, Ciro
    Puccio, Giuseppe
    Chimenz, Roberto
    Pecoraro, Carmine
    Massella, Laura
    Peruzzi, Licia
    Montini, Giovanni
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (03): : 449 - 451
  • [25] Impact of the COVID-19 pandemic on acute appendicitis in children
    Delgado-Miguel, C.
    Urban, J. Garcia
    Ferrer, C. Del Monte
    Munoz-Serrano, A.
    Miguel-Ferrero, M.
    Martinez, L.
    JOURNAL OF HEALTHCARE QUALITY RESEARCH, 2022, 37 (04) : 225 - 230
  • [26] Assessing the change in the epidemiology of seasonal respiratory viruses with the onset of the COVID-19 pandemic
    Kara, Yalcin
    Kizil, Mahmut Can
    Nepesov, Merve Iseri
    Kacmaz, Ebru
    Kiral, Eylem
    Bozan, Gurkan
    Durmaz, Gul
    Us, Tercan
    Kilic, Omer
    Dinleyici, Ener Cagri
    JOURNAL OF GENERAL VIROLOGY, 2024, 105 (05)
  • [27] Impact of covid-19 pandemic on routine immunization of children
    Manzoor, Ammara
    Abbasi, Nazia Bashir
    Khizar, Naila
    Khalil, Muhammad
    Anjum, Sehrish
    Iqbal, Amjad
    RAWAL MEDICAL JOURNAL, 2022, 47 (01): : 45 - 48
  • [28] The Impact and Perceptions of the COVID-19 Pandemic on Children and Adolescents
    Vural, Birgul
    Gurhan, Nermin
    Genis, Bahadir
    Bingol, Tulay Yilmaz
    JOURNAL OF PEDIATRIC INFECTION, 2024, 18 (04): : e221 - e229
  • [29] The surge of RSV and other respiratory viruses among children during the second COVID-19 pandemic winter season
    Riepl, Angela
    Strassmayr, Lena
    Voitl, Peter
    Ehlmaier, Paulina
    Voitl, Julian J. M.
    Langer, Klara
    Kuzio, Ulrike
    Muehl-Riegler, Alexandra
    Muehl, Bernhard
    Diesner-Treiber, Susanne C.
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [30] Impact of the COVID-19 Pandemic on Tuberculosis Control: An Overview
    Alene, Kefyalew Addis
    Wangdi, Kinley
    Clements, Archie C. A.
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2020, 5 (03)